Products

Anti-CD30 × Anti-CD16A Bispecific Antibody (TandAb, AFM13) (BSAB-L012)

Recombinant Anti-CD30 × Anti-CD16A Bispecific Antibody (TandAb). This bsAb has been generated by applying the Crossmab format to generate an IgGshaped entity that binds each ligand with one arm. It was designed for the treatment of Hodgkin's Lymphoma.      

Specifications
Targets
CD30 & CD16A
Type
TandAb
Expression Host
CHO
Species Reactivity
Human
Target 1
CD30
Host
Mouse
Target 2
CD16A
Host
Human
Purity
>95% judged by SDS-PAGE under reducing condition
Related Disease
Hodgkin's Lymphoma
Targets
Target 1
CD30
Gene ID
943
UniProt ID
P28908
Alternative Names
CD30; Ki-1; D1S166E
Target 2
CD16A
Gene ID
2214
UniProt ID
P08637
Alternative Names
CD16; FCG3; CD16A; FCGR3; IGFR3; IMD20; FCR-10; FCRIII; FCGRIII; FCRIIIA

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-381-2994    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2018 Creative-Biolabs All Rights Reserved